Document is current
Any future updates will be listed below
-
Authors
Mizuno, Kanako https://orcid.org/0009-0005-1874-7553
Inose, Ryo https://orcid.org/0000-0003-4874-0377
Muraki, Yuichi https://orcid.org/0000-0001-6951-5676
- License Information
-
More Information
Article History
Received: 10 September 2025
Accepted: 27 November 2025
First Online: 8 December 2025
Declarations
:
: This study was approved by the Ethics Committee of Kyoto Pharmaceutical University (approval number: E-00031). The requirement for informed consent was waived owing to the anonymized nature of the study data.
: Not applicable.
: RI received funding for the commissioned research from the Kowa Company, Ltd. However, this study was not directly funded.YM is editor of the Journal of Pharmaceutical Health Care and Sciences . Other authors declare that they have no competing interests. YM received grants from Pfizer Japan Inc.; Kowa Company Ltd.; the Japan Pharmaceutical Association; the Japan Society for the Promotion of Science; and the Ministry of Health, Labour and Welfare. YM is also a board member of the Japanese Society of Pharmaceutical Health Care and Sciences and the Japanese Society for Infection Prevention and Control, and a committee member of the AMR Clinical Reference Center.The other authors have no conflicts of interest to declare.
